aminaftone has been researched along with endothelin-1 in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Beretta, L; Colombo, G; Lenna, S; Salazar, G; Santaniello, A; Scorza, R; Turcatti, F | 1 |
| Beretta, L; Fumagalli, F; Latini, R; Masson, S; Santaniello, A; Scorza, R; Zambelli, V | 1 |
| Burchielli, S; Da Pozzo, E; Di Stefano, R; Felice, F; Frullini, A; Martini, C | 1 |
3 other study(ies) available for aminaftone and endothelin-1
| Article | Year |
|---|---|
Aminaftone, a derivative of 4-aminobenzoic acid, downregulates endothelin-1 production in ECV304 Cells: an in vitro Study.
Topics: 4-Aminobenzoic Acid; Aspartic Acid Endopeptidases; Cell Line; Down-Regulation; Endothelial Cells; Endothelin-1; Endothelin-Converting Enzymes; Endothelium, Vascular; Enzyme-Linked Immunosorbent Assay; Hemostatics; Humans; Interleukin-1beta; Metalloendopeptidases; para-Aminobenzoates; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger | 2008 |
Efficacy of aminaftone in a rat model of monocrotaline-induced pulmonary hypertension.
Topics: 4-Aminobenzoic Acid; Animals; Body Weight; Cardiomegaly; Disease Models, Animal; Endothelin-1; Hemodynamics; Hypertension, Pulmonary; Male; Monocrotaline; para-Aminobenzoates; Pulmonary Artery; Rats; Rats, Wistar; Survival Analysis | 2011 |
Prevention of excessive endothelin-1 release in sclerotherapy: in vitro and in vivo studies.
Topics: Animals; Cell Survival; Cumulus Cells; Dietary Supplements; Endothelin-1; Hemostatics; Human Umbilical Vein Endothelial Cells; Humans; Male; para-Aminobenzoates; Rats; Rats, Wistar; Sclerosing Solutions; Sclerotherapy | 2014 |